NME1-NME2 Rabbit pAb - Human NME1-NME2

Core Product Specifications and Parameters

Experimental Guidance and Technical Tips

• The immunogen is a recombinant fusion protein spanning amino acids 1–267, offering broad epitope coverage. For assay optimization, consider testing multiple batches or dilution ranges.
• For western blot (WB), start with standard lysate loading (e.g., 20 µg) and optimize antibody dilution in the range of 1:500–1:2000. Validate specificity with positive and negative controls in the target species.
• In ELISA applications, this antibody is suitable for indirect formats. Coating with the target protein or immunogen may be required; validate background and sensitivity in the relevant sample matrix.
• Reported cross-reactivity includes human, mouse, and rat. For other species, perform sequence alignment and pilot experiments to confirm reactivity.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers, laboratories, and research institutes with a comprehensive one-stop sourcing platform for IVD raw materials. This product targets the NME1-NME2 fusion protein, a key biomarker in cancer metastasis research, supporting your assay pipeline from concept to clinic. Our supply portfolio includes validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and tailored sourcing for rare targets—streamlining your procurement while maintaining quality and consistency.